Here you can read a medical review of Re5 depression treatment (T-PEMF), including research and evidence, mechanism of action and clinical application.

Depression treatment is evolving and in addition to several cognitive therapy methods and antidepressant medication, there are several non-pharmacological treatments used daily in hospitals: ECT, TMS and T-PEMF.

TMS and T-PEMF are still not implemented in all sectors of psychiatry. In general, treatment with ECT and TMS is only possible in hospitals. The Re5 depression treatment (T-PEMF) does not require hospitalization, but generally requires longer treatment time (up to 8 weeks).

The advantages of Re5 depression treatment are the possibility of completing the treatment at home (if the patient is compliant) and the side effect profile is very mild.

The key elements of Re5 depression treatment are:

• Good clinical outcomes in independent randomized studies, although there is less evidence compared to TMS and ECT
• Certified under EU MDR (2017/745), the new comprehensive European legislation for medical devices
• Fewer side effects, greater safety and comfort compared to TMS and ECT, including the ability to self-treat at home after instruction
• User-friendly and convenient - implements and works smoothly in your clinic
• Increased flexibility for clinicians and patients (home treatment)

Read on to find out how you can improve your current treatment offering with Re5 depression treatment and how to integrate Re5 treatment into your clinic.

With Re5 depression treatment, you will have an option for patients who do not respond or experience unacceptable side effects to traditional antidepressant treatment regimens and you will have the opportunity to improve your patients' outcomes.

You can always contact us for more information about Re5 depression treatment and how to get started with the treatment in your clinic.